PEDF inhibits VEGF-mediated reactive oxygen species (ROS) generation, decreases anti-apoptotic and growth-promoting factor, increases myeloid cell leukaemia 1 (Mcl-1) expression, and reduces proliferation of multiple myeloma (MM) cells [51]. The gene discussed is VEGFA; the disease is Miyoshi myopathy.